Daily Archives: July 10, 2023
Practice Recommendation | Strategies to prevent MRSA transmission and infection in hospitals
10 Jul, 2023 | 14:02h | UTCCommentary: New guidelines recommend antibiotic stewardship for preventing MRSA – CIDRAP
Guideline | Acute liver failure
10 Jul, 2023 | 13:59h | UTCAcute Liver Failure Guidelines – The American Journal of Gastroenterology
Related:
EASL Clinical Practice Guidelines on acute-on-chronic liver failure – Journal of Hepatology
Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU
Acute-on-chronic liver failure: far to go—a review – Critical Care
RCT | Dual antiplatelet therapy proves noninferior to alteplase in minor ischemic stroke
10 Jul, 2023 | 13:58h | UTCDual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke: The ARAMIS Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
See also: Visual Abstract
RCT | No significant difference in weight loss between intermittent fasting and calorie restriction
10 Jul, 2023 | 13:56h | UTCTime-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Intermittent fasting and traditional calorie counting shown to be about equal for weight loss – American College of Physicians
Commentary: Intermittent fasting and calorie counting about equal for weight loss – new study – The Conversation
Related:
Time-Restricted Eating: Integrating The What With The When – Advances in Nutrition
Global Burden of Disease Study | Understanding global trends of infectious diseases in younger population, 1990-2019
10 Jul, 2023 | 13:54h | UTCNews Release: Global efforts to reduce infectious diseases must extend beyond early childhood – Murdoch Children’s Research Institute
Commentary: Global infectious disease burden shifting from younger to older youth – CIDRAP
AAP Clinical Report | Assessment and management of inguinal hernias in children
10 Jul, 2023 | 13:50h | UTCAssessment and Management of Inguinal Hernias in Children – Pediatrics
News Release: AAP report on managing inguinal hernias addresses common questions, controversies – AAP News
Commentary: AAP issues guidance on inguinal hernias – MDedge
AAP Policy Statement | Child pedestrian safety
10 Jul, 2023 | 13:44h | UTCChild Pedestrian Safety – Pediatrics
Technical Report: Epidemiology and Prevention of Child Pedestrian Injury – Pediatrics
News Release: Speed, technology, road design are key factors in reducing pedestrian injuries – AAP News
AAP Clinical Report | Intimate partner violence: role of the pediatrician
10 Jul, 2023 | 13:42h | UTCIntimate Partner Violence: Role of the Pediatrician – Pediatrics
News Release: Intimate partner violence: Guidance focuses on children, teens exposed in the home – AAP News
Canadian Guidance | Deceased organ and tissue donation after medical assistance in dying
10 Jul, 2023 | 13:41h | UTCCommentary: What happens to the organs of people who choose medically assisted deaths? – CTV News
Cohort Study | A diet high in fruits, vegetables, nuts, legumes, fish, and dairy linked with decreased mortality and CVD globally
10 Jul, 2023 | 13:39h | UTCDiet, cardiovascular disease, and mortality in 80 countries – European Heart Journal
News Release: Global diet study challenges advice to limit high-fat dairy foods – European Society of Cardiology
Commentary on Twitter
Fruits, vegetables, nuts, legumes, fish and dairy: the secret to a lower risk of cardiovascular risk and mortality! Read the Prospective Urban Rural Epidemiology study on #EHJ!#diet #cardiovascular #risk #cardiotwitter #EHJ @ESC_Journals @escardio https://t.co/uzDYdhf6DI pic.twitter.com/54ZN3pa6cN
— EHJ Editor-in-Chief (@ehj_ed) July 9, 2023
Review | Evaluation of acute adult disorders of consciousness for the general intensivist
10 Jul, 2023 | 13:37h | UTCState-of-the-Art Evaluation of Acute Adult Disorders of Consciousness for the General Intensivist – Critical Care Medicine (free for a limited period)
Personalized nutrition therapy in critical care: 10 expert recommendations
10 Jul, 2023 | 13:36h | UTCPersonalized nutrition therapy in critical care: 10 expert recommendations – Critical Care
How to avoid harm with feeding critically ill patients: a synthesis of viewpoints of a basic scientist, dietitian and intensivist
10 Jul, 2023 | 13:34h | UTC
RCT | Atezolizumab in platinum-ineligible NSCLC elevates median survival to 10.3 months vs. 9.2 months with chemotherapy
10 Jul, 2023 | 13:33h | UTCFirst-line atezolizumab monotherapy versus single-agent chemotherapy in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen (IPSOS): a phase 3, global, multicentre, open-label, randomised controlled study – The Lancet (link to abstract – $ for full-text)
News Release: Immunotherapy for ‘difficult to treat’ lung cancer patients improves long-term survival – University College London
RCT | Perioperative nivolumab plus chemotherapy increases pathological response vs. chemotherapy alone in stage III NSCLC
10 Jul, 2023 | 13:27h | UTCPerioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Addition of Neoadjuvant Nivolumab to Platinum-Based Chemotherapy in Stage III NSCLC – The ASCO Post
Commentary on Twitter
Original Article: Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung Cancer https://t.co/DCcs0tkyPN #oncology pic.twitter.com/0zG9SUbqQj
— NEJM (@NEJM) June 30, 2023
Cohort Study | Hypertensive disorders of pregnancy linked to a 66% higher stroke risk in U.S. black women
10 Jul, 2023 | 13:31h | UTCHypertensive Disorders of Pregnancy and Risk of Stroke in U.S. Black Women – NEJM Medicine
RCT | Mirikizumab outperforms placebo in inducing and maintaining remission in ulcerative colitis
10 Jul, 2023 | 13:25h | UTCMirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Mirikizumab Bests Placebo in Treating Patients With Ulcerative Colitis – HCP Live
Commentary on Twitter
In two placebo-controlled, phase 3 trials, mirikizumab, a p19-directed anti–interleukin-23 antibody, was superior with regard to clinical remission of ulcerative colitis at 12 weeks (induction) and 40 weeks (maintenance). https://t.co/H4reu33hF1
— NEJM (@NEJM) June 28, 2023
M-A | Efficacy of varenicline versus bupropion for smoking cessation
10 Jul, 2023 | 13:23h | UTC
Podcast | Untangling catheter associated UTIs
10 Jul, 2023 | 13:21h | UTC#402 Don’t Get Caught with a CAUTI – The Curbsiders
Podcast | Updates in addiction medicine
10 Jul, 2023 | 13:17h | UTC#401 Updates in Addiction Medicine – SGIM 2023 – The Curbsiders